NCT02498418View on ClinicalTrials.gov

Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea

PHASE3CompletedINTERVENTIONAL
Enrollment

739

Participants

Timeline

Start Date

January 6, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Diarrhea
Interventions
DRUG

Rifaximin

Tablets, generic formulation of the brand product.

DRUG

Xifaxan®

Tablets, brand product.

DRUG

Placebo Tablet

Placebo tablets in the same image of the generic rifaximin. Has no active ingredient.

Trial Locations (1)

33134

Site 1, Coral Gables

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT02498418 - Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's Diarrhea | Biotech Hunter | Biotech Hunter